Barclays lowered the firm’s price target on Bath & Body Works to $38 from $43 and keeps an Equal Weight rating on the shares post the Q4 report. The company’s guidance is predicated on a continuation of challenging macro environment and looks concretive, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Buy Rating Affirmed for Bath & Body Works Amid Strong Financials and Strategic Growth Initiatives
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Dell reports mixed Q4 results, Intel delays Ohio chip factory: Morning Buzz
- Walgreens downgraded, Cava Group upgraded: Wall Street’s top analyst calls
- Bath & Body Works price target raised to $47 from $45 at Baird